SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001511164-17-000713
Filing Date
2017-11-21
Accepted
2017-11-21 10:52:12
Documents
1
Period of Report
2017-11-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 2201
  Complete submission text file 0001511164-17-000713.txt   3832
Mailing Address 1801 CENTURY PARK EAST 24TH FLOOR LOS ANGELES CA 90067
Business Address 1801 CENTURY PARK EAST 24TH FLOOR LOS ANGELES CA 90067 866-443-4666
Hoverink Biotechnologies, Inc. (Issuer) CIK: 0001586494 (see all company filings)

IRS No.: 463590875 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10250 CONSTELLATION BLVD SUITE 2300 CENTURY CITY CA 90067
Business Address
Sajna Davidra Nicole (Reporting) CIK: 0001653739 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-55055 | Film No.: 171215692